Document ID: chunk:federal_register_of_legislation:F2022L00013:reg:9:p2
Version: federal_register_of_legislation:F2022L00013
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 7285–10332

3 deiodinase-overexpressing neoplasm before the clinical onset of hypothyroidism;
(16)      having hypopituitarism involving deficiency of thyroid-stimulating hormone at the time of the clinical onset of hypothyroidism;
(17)      having chronic kidney disease at the time of the clinical onset of hypothyroidism;
Note: chronic kidney disease is defined in the Schedule 1 - Dictionary.
(18)      having hepatitis C virus infection at the time of the clinical onset of hypothyroidism;
(19)      being obese for at least 5 years before the clinical onset of hypothyroidism;
Note: being obese is defined in the Schedule 1 - Dictionary.
(20)      having posttraumatic stress disorder at the time of the clinical onset of hypothyroidism;
(21)      for hypothyroidism first presenting as myxoedema coma only, having an acute precipitating event within the 48 hours before the clinical onset of hypothyroidism;
            Note: acute precipitating event and myxoedema coma are defined in the Schedule 1 - Dictionary.
(22)      having iodine deficiency within the 6 months before the clinical worsening of hypothyroidism;
Note: iodine deficiency is defined in the Schedule 1 - Dictionary.
(23)      having iodine excess within the 6 months before the clinical worsening of hypothyroidism;
            Note 1: Iodine excess may be due to consuming foods, dietary supplements or medications with a high content of iodine.
Note 2: iodine excess is defined in the Schedule 1 - Dictionary.
(24)      being administered an iodine-containing radiographic contrast agent within the 6 months before the clinical worsening of hypothyroidism;
(25)      taking a drug from the specified list of drugs within the 6 months before the clinical worsening of hypothyroidism;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(26)      taking minocycline for at least 6 months within the 9 months before the clinical worsening of hypothyroidism;
(27)      taking a drug containing at least 10 milligrams of iodine daily for a continuous period of at least 4 weeks within the 6 months before the clinical worsening of hypothyroidism;
(28)      taking amiodarone for a continuous period of at least 2 weeks within the 1 year before the clinical worsening of hypothyroidism;
(29)      taking a drug that increases the requirement of thyroid hormone replacement therapy at the time of the clinical worsening of hypothyroidism;
            Note: Examples of drugs that may increase the requirement for thyroid hormone replacement therapy include 5-fluorouracil, antiretroviral drugs, clofibrate, raloxifene and tamoxifen.
(30)      being pregnant or within the 12 months postpartum at the time of the clinical worsening of hypothyroidism;
(31)      having a form of thyroiditis from the specified list of forms of thyroiditis at the time of the clinical worsening of hypothyroidism;
Note: specified list of forms of thyroiditis is defined in the Schedule 1 - Dictionary.
(32)      undergoing a course of therapeutic radiation for cancer, where the thyroid